Swing Therapeutics Stock

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

Sign up today and learn more about Swing Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Swing Therapeutics Stock

Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

Funding History

August 2021$9.0M
June 2022$10.3M

Management

CEO

Mike Rosenbluth

Head of Software Engineering

Eric Hoppe

Head of Product

Nelson Mitchell

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo